2016 annual financial data
Aptevo Therapeutics 2016 Net margin
Aptevo Therapeutics 2016 net margin with verified reported values.
Direct answer
Net margin was -308.54%.
Operating income was -126,945,000 USD and net income was -112,415,000 USD.
Operating cash flow was -36,862,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,434,000 USD
- Operating income
- -126,945,000 USD
- Net income
- -112,415,000 USD
- Operating cash flow
- -36,862,000 USD